RadioBDC Logo
My Hero | Foo Fighters Listen Live
THIS STORY HAS BEEN FORMATTED FOR EASY PRINTING
Around the Region

FDA clears new device for Covidien

Globe Staff / December 2, 2011
Text size +
  • E-mail
  • E-mail this article

    Invalid E-mail address
    Invalid E-mail address

    Sending your article

    Your article has been sent.

Covidien PLC, the medical supplies giant that is incorporated in Ireland but has its corporate headquarters in Mansfield, said that its SpiderFX device has received clearance from the Food and Drug Administration. The SpiderFX is an embolic protection device that is used to treat severely calcified lesions in conjunction with plaque excision in arteries, the company said in a press release. Embolic protection devices are used to capture and remove debris that becomes dislodged during an interventional procedure.

For more from BostonGlobe.com, sign up or log in below

To continue, please sign up or log in to BostonGlobe.com

Access the full articles and quality reporting of The Boston Globe at BostonGlobe.com

Sign up

Unlimited Access to BostonGlobe.com for 4 weeks for only 99¢.

Are you a Boston Globe home delivery subscriber?

Get FREE access as part of your print subscription.

BostonGlobe.com subscriber

Click to continue reading this article or to log in to BostonGlobe.com.
  • E-mail
  • E-mail this article

    Invalid E-mail address
    Invalid E-mail address

    Sending your article

    Your article has been sent.